The University of Chicago Header Logo

Connection

Gini Fleming to Anilides

Back to Details
This is a "connection" page, showing publications Gini Fleming has written about Anilides.
Gini Fleming
Connection Strength
0.364
Anilides
  1. Translational randomized phase II trial of cabozantinib in combination with nivolumab in advanced, recurrent, or metastatic endometrial cancer. J Immunother Cancer. 2022 03; 10(3).
    View in: PubMed
    Score: 0.195
  2. Phase II Trial of Cabozantinib in Recurrent/Metastatic Endometrial Cancer: A Study of the Princess Margaret, Chicago, and California Consortia (NCI9322/PHL86). Clin Cancer Res. 2020 06 01; 26(11):2477-2486.
    View in: PubMed
    Score: 0.169
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.